Advertisement

Topics

Pathway Alterations Predict Response to HER2-Targeted Therapies in Breast Cancer

03:00 EDT 19 Oct 2016 | Cancer Networks

Response to the HER2-targeted therapies lapatinib and trastuzumab are correlated with pathway-level genetic alterations, but not specific gene mutations.

Original Article: Pathway Alterations Predict Response to HER2-Targeted Therapies in Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Pathway Alterations Predict Response to HER2-Targeted Therapies in Breast Cancer"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...